Bay Shore Trust 4
4 · Telomir Pharmaceuticals, Inc. · Filed Feb 15, 2024
Insider Transaction Report
Form 4
Bay Shore Trust
10% Owner
Transactions
- Purchase
Common Stock
2024-02-13$7.00/sh+49,000$343,000→ 5,455,431 total(indirect: By Trust) - Purchase
Common Stock
2024-02-13$7.00/sh+40,000$280,000→ 1,365,646 total(indirect: See Footnote) - Purchase
Common Stock
2024-02-13$7.00/sh+49,000$343,000→ 1,902,659 total(indirect: By Trust)
Holdings
- 24,391
Common Stock
- 2,439,025(indirect: By Trust)
Common Stock (right to buy)
Exercise: $3.73From: 2023-06-15Exp: 2028-06-15→ Common Stock (2,439,025 underlying)
Footnotes (4)
- [F1]These securities are owned directly by the Bay Shore Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Brian McNulty ("Mr. McNulty") as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F2]These securities are owned directly by the MIRALOGX, LLC, of which the Trust holds all of the membership interests, and indirectly by Mr. McNulty as trustee of the Trust. Mr. McNulty disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- [F3]These securities are owned directly by a trust for which Mr. McNulty serves as trustee. Mr. McNulty disclaims beneficial ownership of the reported securities because he is deemed to hold these securities only because of his role as Trustee and does not have any pecuniary interest in such securities.
- [F4]These securities are owned directly by Mr. McNulty.